An anonymous reader writes: The Indian Supreme Court on Monday dismissed the plea of Swiss pharma giant Novartis AG for getting its blood cancer drug Glivec patented in India.The court rejected the claims of Swiss pharma giant and said the patents would be granted only for genuine inventions. This paves the way for Indian companies to manufacture generic drugs for cancer and make it available for rest of the developing world as well.
Attend or create a Slashdot 20th anniversary party! DEAL: For $25 - Add A Second Phone Number To Your Smartphone for life! Use promo code SLASHDOT25. Check out the new SourceForge HTML5 Internet speed test. ×